Literature DB >> 6217216

Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro.

T Ochi, E A Goldings, P E Lipsky, M Ziff.   

Abstract

Procainamide (PA) induces the production of a number of autoantibodies in a high proportion of treated individuals and in some a syndrome closely resembling systemic lupus erythematosus. The mechanism underlying this action of PA is unclear. To examine the possibility that PA might induce autoantibody formation by altering normal immunoregulatory mechanisms, the action of this drug on an in vitro model of antibody formation in man was examined. PA was found to augment the generation of immunoglobulin-secreting cells (ISC) from human peripheral blood mononuclear cells (PBM) in response to pokeweed mitogen but had no effect on pokeweed mitogen-induced tritiated thymidine incorporation. When purified populations of B and T cells were used, PA enhanced the generation of ISC in B-cell cultures supported by untreated T cells but not by T cells treated with mitomycin C. These results indicate that PA augmented B-cell responses by inhibiting suppressor T-cell activity and not by augmenting helper T-cell or B-cell function. N-Acetyl-procainamide had no effect on the generation of ISC in this system. The effect of PA on concanavalin A (Con A)-induced suppressor cell activity was also examined to determine whether PA altered the generation or expression of suppressor T-cell function. PBM were cultured with 30 microgram/ml of Con A for 48 h to generate suppressor cells. When these were co-cultured with fresh PBM, the number of ISC generated was decreased by 58.1 +/- 3.4% (mean +/- SEM, n = 6). Cells that had been similarly incubated without Con A were not inhibitory. The addition of PA to the Con A-stimulated cultures inhibited the generation of suppressor cells as indicated by the fact that the response of fresh cells co-cultured with the Con A-stimulated cells was diminished by only 27.2 +/- 4.3%. In this system too, N-acetyl-procaimamide had no effect. By contrast, adding PA only to the co-culture of Con A-stimulated cells with fresh PBM had a less marked effect on suppressor cell function. These results indicate that the major action of PA is to inhibit the generation of suppressor T-cell activity. Such an effect may explain the capacity of this agent to induce autoantibody formation in treated individuals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217216      PMCID: PMC436835          DOI: 10.1172/jci110749

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide.

Authors:  E F Gold; S Ben-Efraim; A Faivisewitz; Z Steiner; A Klajman
Journal:  Clin Immunol Immunopathol       Date:  1977-03

2.  Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Drug-induced autoimmune disease.

Authors:  E M Tan
Journal:  Fed Proc       Date:  1974-08

4.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.

Authors:  R L Woosley; D E Drayer; M M Reidenberg; A S Nies; K Carr; J A Oates
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

6.  Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome.

Authors:  H G Bluestein; N J Zvaifler; M H Weisman; R F Shapiro
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

7.  Development of antibodies to ribonucleoprotein following short-term therapy with procainamide.

Authors:  J B Winfield; D Koffler; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

8.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

9.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

10.  Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells.

Authors:  S A Rosenberg; P E Lipsky
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

View more
  8 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat.

Authors:  C D Pusey; C Bowman; A Morgan; A P Weetman; B Hartley; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 3.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro.

Authors:  R L Rubin; J T Curnutte
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 5.  Haematological effects of non-narcotic analgesics.

Authors:  P A Miescher; W Pola
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide.

Authors:  Y Shoenfeld; Y Vilner; T Reshef; A Klajman; A Skibin; O Kooperman; R C Kennedy
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

7.  Procainamide elicits a selective autoantibody immune response.

Authors:  R L Rubin; G Reimer; E M McNally; S R Nusinow; R P Searles; E M Tan
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

8.  Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups.

Authors:  G de Boccardo; D Drayer; A L Rubin; A Novogrodsky; M M Reidenberg; K H Stenzel
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.